Home > Boards > US Listed > Biotechs > BioMarin Pharmaceutical Inc. (BMRN)

According to WhaleWisdom, BMRN is Baker Bro 6th

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
chmcnfunds Member Profile
 
Followed By 69
Posts 11,686
Boards Moderated 0
Alias Born 12/25/09
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/12/2021 7:22:31 PM
BioMarin Announces 6 Presentations at American Society of Gene and Cell Therapy (ASGCT) Virtual 2021 Annual Meeting PR Newswire (US) - 5/12/2021 8:31:00 AM
BioMarin to Participate in Two Upcoming Virtual Investor Conferences PR Newswire (US) - 5/3/2021 8:30:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 4/30/2021 2:11:36 PM
BioMarin Reports Better-Than-Expected 1Q Results TipRanks - 4/30/2021 5:42:51 AM
PDUFA date for BioMarin's vosoritide extended by three months Seeking Alpha - 4/29/2021 5:49:55 PM
BioMarin Pharmaceutical EPS beats by $0.19, beats on revenue Seeking Alpha - 4/29/2021 4:10:48 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/29/2021 4:10:33 PM
BioMarin Announces First Quarter 2021 Financial Results and Corporate Updates PR Newswire (US) - 4/29/2021 4:03:00 PM
BioMarin Pharmaceutical Q1 2021 Earnings Preview Seeking Alpha - 4/28/2021 5:35:16 PM
Biomarin and Allen Institute team up to develop gene therapies Seeking Alpha - 4/28/2021 8:59:31 AM
Allen Institute and BioMarin Team Up To Develop Gene Therapies For Rare Brain Diseases PR Newswire (US) - 4/28/2021 8:31:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/19/2021 4:10:06 PM
BioMarin posts positive updated phase 2 data on vosoritide for achondroplasia Seeking Alpha - 4/15/2021 9:49:12 AM
BioMarin reports encouraging vosoritide data in achondroplasia Seeking Alpha - 4/15/2021 9:07:17 AM
BioMarin Announces New and Updated Data at 2021 American College of Medical Genetics and Genomics (ACMG) Annual Clinical Gene... PR Newswire (US) - 4/15/2021 8:31:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 4/13/2021 4:32:28 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/13/2021 4:32:19 PM
BioMarin to Host First Quarter 2021 Financial Results Conference Call and Webcast on Thursday, April 29 at 4:30pm ET PR Newswire (US) - 4/13/2021 8:30:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/9/2021 5:58:10 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/2/2021 7:35:35 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/1/2021 2:17:48 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/26/2021 5:46:25 PM
BioMarin presents data supporting long-term benefit of vosoritide in achondroplasia Seeking Alpha - 3/21/2021 12:09:18 AM
BioMarin Announces Oral Presentation at ENDO2021, the Endocrine Society's Annual Meeting, with Data Demonstrating 2 Years of ... PR Newswire (US) - 3/20/2021 11:15:00 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences